http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1191039-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04 |
| filingDate | 1968-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca2a4439a91bd4751fccd8983478442d |
| publicationDate | 1970-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1191039-A |
| titleOfInvention | Benzimidazole Methanesulphonates |
| abstract | 1,191,039. Methanesulphonic acid salts of benzimidazoles. MERCK & CO. Inc. 12 Aug., 1968 [17 Aug., 1967], No. 38487/68. Heading C2C. A 2-substituted-benzimidazole methane-sulphonic acid addition salt wherein the 2-substituent is an aryl radical, e.g. phenyl and halophenyl, or heteroaryl radical, e.g. furyl, pyrryl, thienyl, thiazolyl, isothiazolyl, and the benzimidazole nucleus optionally has, at one or more of the 4, 5, 6 and 7 positions, a halogen, C 1-5 alkyl, C 1-5 alkoxy, trifluoro-alkyl, phenyl, halophenyl or phenoxy substituent, and optionally has, at the 1-position, a C 1-5 alkyl, C 1-5 alkoxy or C 2-5 alkenyl substituent, is obtained by reacting methanesulphonic acid with a 2- substituted-benzimidazole. Pharmaceutical preparations effective in controlling helminthiasis contain as active ingredient a salt as defined above; administration is orally, parenterally, intramuscularly and subcutaneously. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9712615-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5958950-A |
| priorityDate | 1967-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.